• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

FDA extends deadline to decide on Gamida Cell's stem cell transplant therapy by three...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 22, 2022 at 04:32: PM
via With commercial preparations already underway, Gamida Cell was keenly eyeing the late January deadline for U.S. regulators to decide on the approval application of its stem cell transplant therapy.

article source
 




Top Bottom
Back
Quote